Darbepoetin Alfa Compared With Epoetin Alfa in Treating Anemia in Patients Receiving Chemotherapy for Cancer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Darbepoetin alfa and epoetin alfa may stimulate red blood cell production and
treat anemia in patients who are receiving chemotherapy. It is not yet known whether
darbepoetin alfa is more effective than epoetin alfa in treating patients with anemia.
PURPOSE: Randomized phase III trial to compare the effectiveness of darbepoetin alfa with
that of epoetin alfa in treating anemia in patients who are receiving chemotherapy for
cancer.